van de Poll-Franse LV - Search Results

1

Impact of cancer on use of glucose-lowering drug treatment in individuals with diabetes: potential mechanisms. Reply to Pouwer F [letter].

Zanders MM, Haak HR, van Herk-Sukel MP, van de Poll-Franse LV, Johnson JA. Zanders MM, et al. Diabetologia. 2015 Jun;58(6):1380-1. doi: 10.1007/s00125-015-3578-8. Epub 2015 Apr 3. Diabetologia. 2015. PMID: 25835727 No abstract available.

2

Less aggressive treatment and worse overall survival in cancer patients with diabetes: a large population based analysis.

van de Poll-Franse LV, Houterman S, Janssen-Heijnen ML, Dercksen MW, Coebergh JW, Haak HR. van de Poll-Franse LV, et al. Int J Cancer. 2007 May 1;120(9):1986-92. doi: 10.1002/ijc.22532. Int J Cancer. 2007. PMID: 17230509

3

New opportunities for drug outcomes research in cancer patients: the linkage of the Eindhoven Cancer Registry and the PHARMO Record Linkage System.

van Herk-Sukel MP, van de Poll-Franse LV, Lemmens VE, Vreugdenhil G, Pruijt JF, Coebergh JW, Herings RM. van Herk-Sukel MP, et al. Eur J Cancer. 2010 Jan;46(2):395-404. doi: 10.1016/j.ejca.2009.09.010. Epub 2009 Oct 5. Eur J Cancer. 2010. PMID: 19811904

4

Half of breast cancer patients discontinue tamoxifen and any endocrine treatment before the end of the recommended treatment period of 5 years: a population-based analysis.

van Herk-Sukel MP, van de Poll-Franse LV, Voogd AC, Nieuwenhuijzen GA, Coebergh JW, Herings RM. van Herk-Sukel MP, et al. Breast Cancer Res Treat. 2010 Aug;122(3):843-51. doi: 10.1007/s10549-009-0724-3. Epub 2010 Jan 8. Breast Cancer Res Treat. 2010. PMID: 20058066

5

Health-related quality of life among thyroid cancer survivors: a systematic review.

Husson O, Haak HR, Oranje WA, Mols F, Reemst PH, van de Poll-Franse LV. Husson O, et al. Clin Endocrinol (Oxf). 2011 Oct;75(4):544-54. doi: 10.1111/j.1365-2265.2011.04114.x. Clin Endocrinol (Oxf). 2011. PMID: 21615448 Review.

6

Disease-specific mortality among stage I-III colorectal cancer patients with diabetes: a large population-based analysis.

van de Poll-Franse LV, Haak HR, Coebergh JW, Janssen-Heijnen ML, Lemmens VE. van de Poll-Franse LV, et al. Diabetologia. 2012 Aug;55(8):2163-72. doi: 10.1007/s00125-012-2555-8. Epub 2012 Apr 24. Diabetologia. 2012. PMID: 22526616 Free PMC article.

7

Development of a disease-specific health-related quality of life questionnaire (THYCA-QoL) for thyroid cancer survivors.

Husson O, Haak HR, Mols F, Nieuwenhuijzen GA, Nieuwlaat WA, Reemst PH, Huysmans DA, Toorians AW, van de Poll-Franse LV. Husson O, et al. Acta Oncol. 2013 Feb;52(2):447-54. doi: 10.3109/0284186X.2012.718445. Epub 2012 Sep 27. Acta Oncol. 2013. PMID: 23013266

8

Effect of diabetes on endometrial cancer recurrence and survival.

Zanders MM, Boll D, van Steenbergen LN, van de Poll-Franse LV, Haak HR. Zanders MM, et al. Maturitas. 2013 Jan;74(1):37-43. doi: 10.1016/j.maturitas.2012.10.007. Epub 2012 Nov 12. Maturitas. 2013. PMID: 23153683

9

Husson O, Haak HR, Buffart LM, Nieuwlaat WA, Oranje WA, Mols F, Kuijpens JL, Coebergh JW, van de Poll-Franse LV. Husson O, et al. Acta Oncol. 2013 Feb;52(2):249-58. doi: 10.3109/0284186X.2012.741326. Epub 2012 Nov 26. Acta Oncol. 2013. PMID: 23181387

10

Rising incidence, no change in survival and decreasing mortality from thyroid cancer in The Netherlands since 1989.

Husson O, Haak HR, van Steenbergen LN, Nieuwlaat WA, van Dijk BA, Nieuwenhuijzen GA, Karim-Kos H, Kuijpens JL, van de Poll-Franse LV, Coebergh JW. Husson O, et al. Endocr Relat Cancer. 2013 Mar 26;20(2):263-71. doi: 10.1530/ERC-12-0336. Print 2013 Apr. Endocr Relat Cancer. 2013. PMID: 23447568

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

398 results

Search Page

Filters